Insulin degludec/Insulin aspart（Hangzhou Zhongmei Huadong）
德谷胰岛素/门冬胰岛素（杭州中美华东）
Report date: 2025/10/27 17:55:04
Base Information
Drug NameInsulin degludec/Insulin aspart（Hangzhou Zhongmei Huadong）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksKEGG